tetano
Editor, Senior Moderator
Emerg Microbes Infect
. 2021 Jun 29;1-32.
doi: 10.1080/22221751.2021.1949948. Online ahead of print.
Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil
Fernando Hayashi Sant'Anna[SUP] 1 [/SUP], Ana Paula Muterle Varela[SUP] 2 [/SUP], Janira Prichula[SUP] 2 [/SUP], Juliana Comerlato[SUP] 1 [/SUP], Carolina Baldisserotto Comerlato[SUP] 1 [/SUP], Vinicius Serafini Roglio[SUP] 1 [/SUP], Gerson Fernando Mendes Pereira[SUP] 3 [/SUP], Flávia Moreno[SUP] 3 [/SUP], Adriana Seixas[SUP] 2 [/SUP], Eliana Márcia Wendland[SUP] 1 4 [/SUP]
Affiliations
Abstract
AbstractIn this study, we analyzed 340 whole genomes of SARS-CoV-2, which were sampled between April and November 2020 in 33 cities of Rio Grande do Sul, South Brazil. We demonstrated the circulation of two novel emergent lineages, VUI-NP13L and VUI-NP13L-like, and five major lineages that had already been assigned (B.1.1.33, B.1.1.28, P.2, B.1.91, B.1.195). P.2 and VUI-NP13L demonstrated a massive spread in October 2020. Constant and consistent genomic surveillance is crucial to identify newly emerging SARS-CoV-2 lineages in Brazil and to guide decision making in the Brazilian Public Healthcare System.
Keywords: Brazil; COVID-19; SARS-CoV-2 genomes; Severe acute respiratory syndrome coronavirus 2; VUI-NP13L.
. 2021 Jun 29;1-32.
doi: 10.1080/22221751.2021.1949948. Online ahead of print.
Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil
Fernando Hayashi Sant'Anna[SUP] 1 [/SUP], Ana Paula Muterle Varela[SUP] 2 [/SUP], Janira Prichula[SUP] 2 [/SUP], Juliana Comerlato[SUP] 1 [/SUP], Carolina Baldisserotto Comerlato[SUP] 1 [/SUP], Vinicius Serafini Roglio[SUP] 1 [/SUP], Gerson Fernando Mendes Pereira[SUP] 3 [/SUP], Flávia Moreno[SUP] 3 [/SUP], Adriana Seixas[SUP] 2 [/SUP], Eliana Márcia Wendland[SUP] 1 4 [/SUP]
Affiliations
- PMID: 34184973
- DOI: 10.1080/22221751.2021.1949948
Abstract
AbstractIn this study, we analyzed 340 whole genomes of SARS-CoV-2, which were sampled between April and November 2020 in 33 cities of Rio Grande do Sul, South Brazil. We demonstrated the circulation of two novel emergent lineages, VUI-NP13L and VUI-NP13L-like, and five major lineages that had already been assigned (B.1.1.33, B.1.1.28, P.2, B.1.91, B.1.195). P.2 and VUI-NP13L demonstrated a massive spread in October 2020. Constant and consistent genomic surveillance is crucial to identify newly emerging SARS-CoV-2 lineages in Brazil and to guide decision making in the Brazilian Public Healthcare System.
Keywords: Brazil; COVID-19; SARS-CoV-2 genomes; Severe acute respiratory syndrome coronavirus 2; VUI-NP13L.